Chromosomal sensitivity to bleomycin in Korean patients with hepatocellular carcinoma.

被引：0
|
作者：
Kim, KC
Han, KH
Seong, IS
Park, HJ
Lee, KS
Chon, CY
Lee, SI
Moon, YM
Park, IS
机构：
[1] YONSEI UNIV,COLL MED,DEPT INTERNAL MED,SEOUL,SOUTH KOREA
[2] YONSEI UNIV,COLL MED,DEPT THERAPEUT RADIOL,SEOUL,SOUTH KOREA
来源：
HEPATOLOGY | 1996年 / 24卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：1623 / 1623
页数：1
相关论文
共 50 条
  • [1] Supplement use in patients with hepatocellular carcinoma.
    Lee, Valerie
    Goyal, Abhishek
    Hsu, Christine Cho-Shing
    Rodriguez, Rosa D.
    Siegel, Abby B.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [2] IMMUNOLOGIC FUNCTION IN PATIENTS WITH HEPATOCELLULAR CARCINOMA.
    Lin, Jiunn-Chang
    Chien, Pei-Ju
    Liu, Chien-Liang
    Lee, Jee-Jen
    Liu, Tsan-Pai
    Ko, Wen-Ching
    Shih, Chwen-Ming
    [J]. LIVER TRANSPLANTATION, 2009, 15 (07) : S146 - S146
  • [3] Hepatocellular carcinoma.
    Lemoine, A
    Azoulay, D
    Jezequel-Cuer, M
    Debuire, B
    [J]. PATHOLOGIE BIOLOGIE, 1999, 47 (09): : 903 - 910
  • [4] Hepatocellular carcinoma.
    Venook A.P.
    [J]. Current Treatment Options in Oncology, 2000, 1 (5) : 407 - 414
  • [5] Induction and expression of cyclin D3 in Korean hepatocellular carcinoma.
    Kang, Y
    Kim, G
    Uhm, K
    Cho, S
    Park, S
    [J]. AMERICAN JOURNAL OF HUMAN GENETICS, 2003, 73 (05) : 222 - 222
  • [6] Molecular characteristics of patients with resectable hepatocellular carcinoma.
    Zeng, Daobing
    Wang, Menglong
    Wu, Jushan
    Lin, Dongdong
    Guo, Qingliang
    Li, Chuanyun
    Zhang, Haitao
    Di, Liang
    Zhao, Xiaofei
    Ma, Chao
    Gao, Daming
    Liu, Zhaobo
    Fu, Zhi
    Sun, Libo
    Zhang, Qikun
    Li, Guangming
    Guo, Rongyun
    Wang, Huina
    Zhang, Yanrui
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [7] Etiologies of cirrhosis by ethnicities of patients with hepatocellular carcinoma.
    Chang, Jeremy
    Ajmera, Veeral
    Fowler, Kathryn J.
    Burgoyne, Adam
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 : 515 - 515
  • [8] A combination of capecitabine and thalidomide in patients with hepatocellular carcinoma.
    Jeong, W.
    Chun, H. G.
    Cer, D.
    Sekhri, V.
    Kim-Schluger, L.
    Wolf, D.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 213S - 213S
  • [9] Analysis of liver transplanted patients for hepatocellular carcinoma.
    Emiroglu, R
    Sozen, H
    Karakayali, F
    Karakayali, H
    Torgay, A
    Yilmaz, U
    Haberal, M
    [J]. LIVER TRANSPLANTATION, 2006, 12 (05) : C47 - C47
  • [10] Lamivudine treatment is beneficial in patients with hepatocellular carcinoma.
    Takagi, S
    Fujioka, S
    Fujio, K
    Kaneyoshi, T
    Kobatake, T
    Araki, Y
    Okamoto, R
    Kobashi, H
    Hashimoto, K
    Senoh, T
    Manabe, K
    Iwasaki, Y
    Shimomura, H
    Sakaguchi, K
    Shiratori, Y
    [J]. HEPATOLOGY, 2002, 36 (04) : 687A - 687A
12345